Among 192 patients with first-ever ischemic stroke, elevated HMGB1 levels early after stroke were an independent predictor of poorer cognitive performance on the Montreal Cognitive Assessment at 3-month follow-up. The gene discussed is HMGB1; the disease is stroke disorder.